Hepatitis C Virus in the Renal Transplant Population: An Update With Focus on the New Era of Antiviral Regimens
Affiliations
Affiliations
- From the Urology and Nephrology Center, Mansoura University, Mansoura, Egypt; and the Hamed Al-Essa Organ Transplant Center, Kuwait.
Abstract
Chronic hepatitis C virus infection is a global health problem, especially among renal transplant recipients. Herein, we present an overview of hepatitis C virus among renal transplant patients, with a focus on some updated aspects concerning types of viral genotypes, methods of diagnosis, the effects of renal transplant on hepatitis C virus infection, and summary of hepatitis C virus-related complications after renal transplant. We also discuss patient and graft survival rates and the present and future therapeutic options with special focus on new antiviral and possible interactions with immunosuppressive medications.
Similar articles
Hepatitis C Virus Infection in Kidney Transplant Patients: Current Treatment Options.
Dzekova-Vidimliski P, Sikole A.Exp Clin Transplant. 2017 Dec;15(6):587-593.PMID: 29219790
Korkmaz M, Fakı S, Öcal S, Harmancı Ö, Ensaroğlu F, Selçuk H, Haberal M.Exp Clin Transplant. 2015 Apr;13 Suppl 1:188-92.PMID: 25894152
Hanif FM, Laeeq SM, Luck NH, Aziz T, Abbas Z, Mubarak M.Exp Clin Transplant. 2017 Feb;15(1):56-60. doi: 10.6002/ect.2016.0034. Epub 2016 Dec 2.PMID: 27915964
New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
Fabrizi F, Martin P, Messa P.Kidney Int. 2016 May;89(5):988-994. doi: 10.1016/j.kint.2016.01.011. Epub 2016 Mar 11.PMID: 27083277 Review.
Hepatitis C and renal transplantation: a review on historical aspects and current issues.
Moghaddam SM, Alavian SM, Kermani NA.Rev Med Virol. 2008 Nov-Dec;18(6):375-86. doi: 10.1002/rmv.590.PMID: 18702126 Review.